HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

California Will Prohibit Use Of Some Cosmetic Ingredients Banned In Europe Beginning in 2025

Executive Summary

Starting in 2025, use of selected preservatives, phthalates and other ingredients already banned in Europe will be prohibited in cosmetics sold in California.

You may also be interested in...



Washington State’s Toxic-Free Cosmetics Act, More Aggressive Than California’s, Awaits Governor’s Signature

The specter of reformulations, market disruptions and potential litigation hangs over Washington state as HB 1047 sits on Governor Jay Inslee’s desk. The Toxic-Free Cosmetics Act, seen by industry stakeholders as a metastasized version of California’s legislation of the same name, would ban the sale of cosmetics containing formaldehyde releasers or trace lead above 1 ppm, in addition to PFAS, ortho-phthalates and other ingredients.

California Eyeing More Cosmetic Ingredient Bans To Align With EU

“In the absence of protective federal action, states must take charge and get toxic chemicals out of our everyday products,” says Scott Faber, senior VP of government affairs at the Environmental Working Group. EWG is sponsoring AB 496, proposed on 7 February by Democratic Assemblymember Laura Friedman.

California’s PFAS Ban In Cosmetics Limited To Intentionally Added Substances, Effective In 2025

Legislation awaiting the governor’s signature in California will ban the “forever chemicals” from cosmetics when intentionally added beginning in 2025, reflecting successful industry advocacy efforts.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150526

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel